Iovance Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.About IOVA
Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors.
CEOFrederick G. Vogt
CEOFrederick G. Vogt
Employees838
Employees838
HeadquartersSan Carlos, California
HeadquartersSan Carlos, California
Founded2007
Founded2007
Employees838
Employees838
IOVA Key Statistics
Market cap996.39M
Market cap996.39M
Price-Earnings ratio-2.10
Price-Earnings ratio-2.10
Dividend yield—
Dividend yield—
Average volume11.52M
Average volume11.52M
High today—
High today—
Low today—
Low today—
Open price$2.26
Open price$2.26
Volume6.85K
Volume6.85K
52 Week high$8.15
52 Week high$8.15
52 Week low$1.64
52 Week low$1.64
Stock Snapshot
Iovance Biotherapeutics(IOVA) stock is priced at $2.52, giving the company a market capitalization of 996.39M. It carries a P/E multiple of -2.10.
On 2025-12-18, Iovance Biotherapeutics(IOVA) stock opened at $2.26, reached a high of —, and a low of —.
The Iovance Biotherapeutics(IOVA)'s current trading volume is 6.85K, compared to an average daily volume of 11.52M.
In the last year, Iovance Biotherapeutics(IOVA) shares hit a 52-week high of $8.15 and a 52-week low of $1.64.
In the last year, Iovance Biotherapeutics(IOVA) shares hit a 52-week high of $8.15 and a 52-week low of $1.64.
IOVA News
TipRanks 20h
Iovance Biotherapeutics Advances Innovative Melanoma Treatment with Updated StudyIovance Biotherapeutics (IOVA) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fun...
Analyst ratings
58%
of 12 ratingsBuy
58.3%
Hold
33.3%
Sell
8.3%
People also own
Based on the portfolios of people who own IOVA. This list is generated using Robinhood data, and it’s not a recommendation.